The primary goal of a clinical chemistry laboratory is to correctly perform analytical procedures that yield accurate and precise information on the constituents of a cell, organelle, tissue, and/or biological fluid to aid in patient diagnosis. Similarly, the primary goal of a drug metabolism laboratory is to correctly perform analytical procedures that yield accurate and precise information on a drug that has been inoculated into a cell culture, an experimental animal, and/or a human being to aid in the understanding of the fate of such a drug (e.g., non-altered intact drug versus a chemically modified drug or metabolite) resulting in cell benefit or toxicity. Routinely, more than 400 common and specialized tests can be performed in a clinical laboratory setting in a single day, and dozens of similar tests can be performed in a drug metabolism laboratory. To accomplish such complex tasks, a variety of methods are currently available, in both types of laboratories, for the determination of a wide range of analytes in simple and complex matrices, including electrophoretic, chromatographic, spectrometric, radiometric, enzymatic, and immunological assays, as well as the measurement of electrolytes by ion-selective electrodes. More recently, capillary electrophoresis (CE) has been added to this battery of traditional tests to determine a large number of substances of small molecular mass, as well as some biomolecules [1,2,3,4,5,6,7,8].Capillary electrophoresis has played a major role in sequencing a number of genomes, providing extensive information on gene sequence, organization, and expression [9, 10]. However, the information gained in the Human Genome Project and many other genome projects is not sufficient to understand the complexity of any living system. The need to study gene products, and the importance in understanding the function of metabolites as active or toxic entities, is becoming the next priority in order to answer questions that genomes alone cannot. In the socalled post-genomic era, proteomics and metabolomics, encompass a group of technologies that attempt to separate, identify, and characterize a global set of proteins and metabolites. A proteome comprises the sequence information for all the proteins present in a cell, organelle, tissue, and/or biological fluid. Moreover, it is beginning to provide information about protein abundance, location, chemical modification, functional activity, interaction networks, and their regulation. Metabolomics comprises the study of the entire metabolite complements in a cell, organelle, tissue, and/or biological fluid. Pharmacokinetic and pharmacodynamic studies are becoming increasingly important in understanding the nature of the interaction of a reactive metabolite, of pharmaceutical and non-pharmaceutical origin, and the various cellular components, as well as the mechanism(s) of action in which these interactions eventually lead to cell benefit or toxicity.Capillary electrophoresis, in capillary format or microchannel format, continues to provide an impre...